Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07572006
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesJanssen Research & Development, LLCNot Yet RecruitingPhase 1
NCT07572006Not Yet Recruiting
Phase 1
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesJanssen Research & Develo...
NCT07573514
Patients With Primary Biliary CholangitisFondazione Policlinico Universitario Agostino Gemelli IRCCSActive Not RecruitingNot Applicable
NCT07573514Active Not Recruiting
Not Applicable
Patients With Primary Biliary CholangitisFondazione Policlinico Un...
NCT07572461
A Single-Arm, Prospective Study of Papaverine for the Treatment of Refractory Peripheral Neuropathy Induced by Taxane-Based ChemotherapySecond Affiliated Hospital, School of Medicine, Zhejiang UniversityNot Yet RecruitingNot Applicable
NCT07572461Not Yet Recruiting
Not Applicable
A Single-Arm, Prospective Study of Papaverine for the Treatment of Refractory Pe...Second Affiliated Hospita...
NCT07573761
Evaluation of the Effectiveness of Odontogenic Grafts Obtained From Human Teeth on Bone FormationIstanbul Saglik Bilimleri UniversityEnrolling By Invitation
NCT07573761Enrolling By Invitation
—
Evaluation of the Effectiveness of Odontogenic Grafts Obtained From Human Teeth...Istanbul Saglik Bilimleri...
NCT07572682
Effects of Dynamic Neuromuscular Stabilization (DNS) and Gyrotonic Training on Shoulder Function in Overhead AthletesSport University of TiranaCompletedNot Applicable
NCT07572682Completed
Not Applicable
Effects of Dynamic Neuromuscular Stabilization (DNS) and Gyrotonic Training on S...Sport University of Tiran...
NCT07573501
Dual-site Cross-frequency Coupled Transcranial Electrical Stimulation Modulates Working Memory of Patients With Post-stroke Cognitive ImpairmentKe Dong, MDNot Yet RecruitingNot Applicable
NCT07573501Not Yet Recruiting
Not Applicable
Dual-site Cross-frequency Coupled Transcranial Electrical Stimulation Modulates...Ke Dong, MD
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07573254
The Effects of Spinal Mobilization Added to an Exercise Program in Recreational Tennis Players With Mechanical Low Back PainIstinye UniversityCompletedNot Applicable
NCT07573254Completed
Not Applicable
The Effects of Spinal Mobilization Added to an Exercise Program in Recreational...Istinye University
NCT07572656
Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe PreeclampsiaMuhammad Aamir LatifCompletedNot Applicable
NCT07572656Completed
Not Applicable
Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe Preecl...Muhammad Aamir Latif
NCT07573228
Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 DiabetesUniversity of VirginiaRecruitingNot Applicable
NCT07573228Recruiting
Not Applicable
Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness...University of Virginia
NCT07573241
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Complementary and Integrative Health (NCCIH)Not Yet RecruitingNot Applicable
NCT07573241Not Yet Recruiting
Not Applicable
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Compl...
NCT07573163
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol SecretionAlaa SadaNot Yet RecruitingPhase 2
NCT07573163Not Yet Recruiting
Phase 2
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol SecretionAlaa Sada
NCT07573462
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy InfantsPfizerNot Yet RecruitingPhase 3
NCT07573462Not Yet Recruiting
Phase 3
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy...Pfizer
NCT07573059
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated PatientsImmedica Pharma US IncRecruitingNot Applicable
NCT07573059Recruiting
Not Applicable
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Pati...Immedica Pharma US Inc
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07573033
Effectiveness of Postoperative Topical and Oral Antibiotics on Impacted Mandibular 3rd Molar Surgery.Liaquat College of Medicine and DentistryCompletedPhase 4
NCT07573033Completed
Phase 4
Effectiveness of Postoperative Topical and Oral Antibiotics on Impacted Mandibul...Liaquat College of Medici...
NCT07571967
AI-Assisted Camera-Based Progressive Muscle Relaxation for Office WorkersIstanbul Medipol University HospitalRecruitingNot Applicable
NCT07571967Recruiting
Not Applicable
AI-Assisted Camera-Based Progressive Muscle Relaxation for Office WorkersIstanbul Medipol Universi...
NCT07572110
Project Independence: Randomized Controlled TrialUniversity of MiamiNot Yet RecruitingNot Applicable
NCT07572110Not Yet Recruiting
Not Applicable
Project Independence: Randomized Controlled TrialUniversity of Miami
NCT07574346
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell MalignanciesPeking University People's HospitalNot Yet RecruitingEarly Phase 1
NCT07574346Not Yet Recruiting
Early Phase 1
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell MalignanciesPeking University People'...
Result Breakdown
Not yet recruiting11 (55%)
Completed4 (20%)
Recruiting3 (15%)
Active, not recruiting1 (5%)
Enrolling by invitation1 (5%)
not_applicable13 (65%)
Phase 12 (10%)
Not Specified1 (5%)
Phase 21 (5%)
Phase 31 (5%)
Phase 41 (5%)
Early Phase 11 (5%)